99% Purity CAS 19171-19-8 Pomalidomide API Pomalidomide Material Pharmaceutical Pomalidomide

• Customization: Available
• Powder: Powder
• Customized: Customized
• Model NO.: D-Sung Pomalidomide
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Product Name: Pomalidomide
• Name: Pomalidomide Powder
• Appearance: Yellow Powder
• Color: Yellow
• Store: Cool and Dry
• Grade: Pharmaceutical Garde
• Assay: HPLC 99%
• Application: Anthelmintics
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 19171-19-8
• Mf: C13h11n3o4
• Refractive Index: 1.691
• Melting Powder: 318.5 - 320.5
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Xi′an Shaanxi
• Production Capacity: 500kg/Month

Product Description

99% Purity CAS 19171-19-8 Pomalidomide API Pomalidomide Material Pharmaceutical Pomalidomide

Product Description

Product Details

Product Name	Pomalidomide
Appearance	Yellow Powder
CAS No.	19171-19-8
MF	C13H11N3O4

Pomalidomide is an orally bioavailable derivative of thalidomide with potential immunomodulating, antiangiogenic and antineoplastic activities. Although its exact mechanism of action has yet to be fully elucidated, pomalidomide appears to inhibit TNF-alpha production, enhance the activity of T cells and natural killer (NK) cells and enhance antibody-dependent cellular cytotoxicity (ADCC). In addition, pomalidomide may inhibit tumor angiogenesis, promote cell cycle arrest in susceptible tumor cell populations, and stimulate erythropoeisis

Application&Function

Pomalidomide is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.

Specification